Skip to main content
. 2019 Dec 18;26(5):341–350. doi: 10.1177/1753425919895086

Figure 5.

Figure 5.

(a) Relationship between serum CXCL12 levels and serum TNF-α levels in IDD patients. (b) Relationship between serum CXCL12 levels and serum IL-6 levels in IDD patients. (c) ROC curve analysis of CXCL12, TNF-α and IL-6 levels between Pfirrmann mild grade and moderate grade. (d) ROC curve analysis of CXCL12, TNF-α and IL-6 levels between Pfirrmann moderate grade and severe grade.